Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
The Lancet. Oncology|April 13, 2016
Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trialOlivier Mir, Claire Cropet, Maud Toulmonde, et al.
Bulletin Du Cancer|March 29, 2023
[Endometrial stromal sarcoma: French Guidelines from the French Sarcoma Group and the Rare Malignant Gynecologic Tumors Group]Coriolan Lebreton, Pierre Meeus, Catherine Genestie, et al.
Plos One|September 19, 2018
EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinibOlivier Bouché, Axel Le Cesne, Maria Rios, et al.
European Journal of Cancer (Oxford, England : 1990)|February 7, 2016
Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life settingStéphane Bouchet, Sylvie Poulette, Karine Titier, et al.
BMC Cancer|February 8, 2013
Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use programJean-Yves Blay, Antoine Italiano, Isabelle Ray-Coquard, et al.
The Lancet. Oncology|June 15, 2013
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trialXavier Pivot, Gilles Romieu, Marc Debled, et al.
The Lancet. Oncology|July 14, 2022
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trialPatricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, et al.
The New England Journal of Medicine|September 4, 2024
Doxorubicin-Trabectedin with Trabectedin Maintenance in LeiomyosarcomaPatricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma GroupNicolas Penel, Axel Le Cesne, Sylvie Bonvalot, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2017
Superimposable outcomes for sequential and concomitant administration of adjuvant trastuzumab in HER2-positive breast cancer: Results from the SIGNAL/PHARE prospective cohortXavier Pivot, Pierre Fumoleau, Jean-Yves Pierga, et al.
Pageof 15